Recent studies have demonstrated that the thyroid hormones triiodo-L-thyronine (T3) and tetraiodo-L-thyronine (T4) enhance EMT activity and the metastasis process via integrin αvβ3, reducing E-cadherin and increasing vimentin expression in ovarian cancer cells (6), but the action of T3 on EMT in BC cells remains to be determined. Here, VIM is linked to ovarian carcinoma.